Cargando…

Topological Optimisation Structure Design for Personalisation of Hydrogel Controlled Drug Delivery System

Personalised controlled drug delivery systems (CDDSs) can adjust drug concentration levels according to patient needs, which has enormous research prospects in precision medicine. In this study, the topological optimisation method was utilised in the structural design of a hydrogel CDDS to achieve a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yang, Li, Tan, Meng, Fanshu, Hou, Zhenzhong, Xu, Chao, Yang, Laixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095648/
https://www.ncbi.nlm.nih.gov/pubmed/37048980
http://dx.doi.org/10.3390/ma16072687
_version_ 1785024133834211328
author Gao, Yang
Li, Tan
Meng, Fanshu
Hou, Zhenzhong
Xu, Chao
Yang, Laixia
author_facet Gao, Yang
Li, Tan
Meng, Fanshu
Hou, Zhenzhong
Xu, Chao
Yang, Laixia
author_sort Gao, Yang
collection PubMed
description Personalised controlled drug delivery systems (CDDSs) can adjust drug concentration levels according to patient needs, which has enormous research prospects in precision medicine. In this study, the topological optimisation method was utilised in the structural design of a hydrogel CDDS to achieve a parameter-based adjustment of the drug average concentration in the hydrogel. A polyacrylamide/sodium alginate dual-network hydrogel was selected as a drug carrier, and tetracycline hydrochloride was used as a model drug. The topological optimisation model of the hydrogel CDDS was developed. The effects of the mesh size, target concentration, and volume factor on the optimised results were investigated. Hydrogel flow channel structures were obtained, which satisfied the different target concentrations. To verify the rationality of the optimisation model, in vitro drug release experiments were carried out. The results show that the hydrogel CDDS can control drug release within 7 days, and the drug release tends to follow zero-order release behaviour. The adjustable average concentration of tetracycline hydrochloride in hydrogel CDDS is recommended in the range of 20.79 to 31.04 mol/m(3). This novel method provides a reference for personalised structure design of CDDS in the context of precision medicine.
format Online
Article
Text
id pubmed-10095648
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100956482023-04-13 Topological Optimisation Structure Design for Personalisation of Hydrogel Controlled Drug Delivery System Gao, Yang Li, Tan Meng, Fanshu Hou, Zhenzhong Xu, Chao Yang, Laixia Materials (Basel) Article Personalised controlled drug delivery systems (CDDSs) can adjust drug concentration levels according to patient needs, which has enormous research prospects in precision medicine. In this study, the topological optimisation method was utilised in the structural design of a hydrogel CDDS to achieve a parameter-based adjustment of the drug average concentration in the hydrogel. A polyacrylamide/sodium alginate dual-network hydrogel was selected as a drug carrier, and tetracycline hydrochloride was used as a model drug. The topological optimisation model of the hydrogel CDDS was developed. The effects of the mesh size, target concentration, and volume factor on the optimised results were investigated. Hydrogel flow channel structures were obtained, which satisfied the different target concentrations. To verify the rationality of the optimisation model, in vitro drug release experiments were carried out. The results show that the hydrogel CDDS can control drug release within 7 days, and the drug release tends to follow zero-order release behaviour. The adjustable average concentration of tetracycline hydrochloride in hydrogel CDDS is recommended in the range of 20.79 to 31.04 mol/m(3). This novel method provides a reference for personalised structure design of CDDS in the context of precision medicine. MDPI 2023-03-28 /pmc/articles/PMC10095648/ /pubmed/37048980 http://dx.doi.org/10.3390/ma16072687 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gao, Yang
Li, Tan
Meng, Fanshu
Hou, Zhenzhong
Xu, Chao
Yang, Laixia
Topological Optimisation Structure Design for Personalisation of Hydrogel Controlled Drug Delivery System
title Topological Optimisation Structure Design for Personalisation of Hydrogel Controlled Drug Delivery System
title_full Topological Optimisation Structure Design for Personalisation of Hydrogel Controlled Drug Delivery System
title_fullStr Topological Optimisation Structure Design for Personalisation of Hydrogel Controlled Drug Delivery System
title_full_unstemmed Topological Optimisation Structure Design for Personalisation of Hydrogel Controlled Drug Delivery System
title_short Topological Optimisation Structure Design for Personalisation of Hydrogel Controlled Drug Delivery System
title_sort topological optimisation structure design for personalisation of hydrogel controlled drug delivery system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095648/
https://www.ncbi.nlm.nih.gov/pubmed/37048980
http://dx.doi.org/10.3390/ma16072687
work_keys_str_mv AT gaoyang topologicaloptimisationstructuredesignforpersonalisationofhydrogelcontrolleddrugdeliverysystem
AT litan topologicaloptimisationstructuredesignforpersonalisationofhydrogelcontrolleddrugdeliverysystem
AT mengfanshu topologicaloptimisationstructuredesignforpersonalisationofhydrogelcontrolleddrugdeliverysystem
AT houzhenzhong topologicaloptimisationstructuredesignforpersonalisationofhydrogelcontrolleddrugdeliverysystem
AT xuchao topologicaloptimisationstructuredesignforpersonalisationofhydrogelcontrolleddrugdeliverysystem
AT yanglaixia topologicaloptimisationstructuredesignforpersonalisationofhydrogelcontrolleddrugdeliverysystem